SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-16-011534
Filing Date
2016-03-11
Accepted
2016-03-11 17:08:13
Documents
67
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2015_actiniumpharma.htm 10-K 1676486
2 THIRD AMENDMENT TO THE 2013 AMENDED AND RESTATED STOCK PLAN, EFFECTIVE AS OF DEC f10k2015ex10xxxxxvi_actinium.htm EX-10.56 7710
3 OFFICE SPACE LICENSE AGREEMENT, DATED MARCH 19, 2016, BY AND BETWEEN ACTINIUM PH f10k2015ex10lvii_actinium.htm EX-10.57 102019
4 LIST OF SUBSIDIARIES f10k2015ex21i_actinium.htm EX-21.1 812
5 CONSENT OF GBH CPAS, PC. f10k2015ex23i_actinium.htm EX-23.1 2256
6 CERTIFICATION f10k2015ex31i_actinium.htm EX-31.1 8577
7 CERTIFICATION f10k2015ex31ii_actinium.htm EX-31.2 7629
8 CERTIFICATION f10k2015ex32i_actinium.htm EX-32.1 3197
9 CERTIFICATION f10k2015ex32ii_actinium.htm EX-32.2 3261
10 GRAPHIC image_001.jpg GRAPHIC 23405
  Complete submission text file 0001213900-16-011534.txt   5782491

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE FILE atnm-20151231.xml EX-101.INS 896635
12 XBRL SCHEMA FILE atnm-20151231.xsd EX-101.SCH 58993
13 XBRL CALCULATION FILE atnm-20151231_cal.xml EX-101.CAL 27083
14 XBRL DEFINITION FILE atnm-20151231_def.xml EX-101.DEF 192148
15 XBRL LABEL FILE atnm-20151231_lab.xml EX-101.LAB 491733
16 XBRL PRESENTATION FILE atnm-20151231_pre.xml EX-101.PRE 319714
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 161501685
SIC: 2834 Pharmaceutical Preparations